FRANKFURT--The following is a summary of analysts' forecasts for
Fresenius Medical Care AG & Co. KGaA (FMS) fourth-quarter
results, based on a poll of nine analysts conducted by Dow Jones
Newswires (figures in million dollars, EPS in dollar, dividend and
target price in euro, according to US-GAAP). Earnings figures are
scheduled to be released February 25.
===
Net
Net attrib. EPS basic
4th Quarter Revenue EBIT EBT income ord.share
AVERAGE 3,860 665 557 334 1.10
Prev. Year 3,706 559 444 257 0.84
+/- in % +4.2 +19 +26 +30 +31
MEDIAN 3,866 667 566 339 1.11
Maximum 3,910 713 571 366 1.15
Minimum 3,810 618 527 308 1.06
Amount (a) 9 9 4 8 5
Bankhaus Lampe 3,866 645 -- 339 1.11
Berenberg 3,868 667 565 342 1.13
Commerzbank 3,810 669 -- -- --
Deutsche Bank 3,907 635 -- 319 1.06
Helvea 3,859 675 571 321 1.06
Warburg Research 3,838 704 -- 341 1.15
Target price Rating DPS 2013
AVERAGE 55.56 positive 5 AVERAGE 0.78
Prev. Quarter 52.43 neutral 4 Prev. Year 0.75
+/- in % +6.0 negative 0 +/- in % +4.3
MEDIAN 55.00 MEDIAN 0.78
Maximum 62.00 Maximum 0.80
Minimum 46.00 Minimum 0.75
Amount 9 Amount 5
Bankhaus Lampe 52.00 Hold 0.75
Berenberg 62.00 Buy 0.78
Commerzbank 61.00 Buy 0.78
Credit Suisse 51.00 Neutral --
Deutsche Bank 46.00 Hold --
Equinet 61.00 Buy --
Helvea 55.00 Hold 0.80
UBS 54.00 Buy --
Warburg Research 58.00 Buy 0.80
===
Year-earlier figures are as reported by the company.
(a) Including anonymous estimates from three more analysts.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires